- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06022107
Social Support Intervention for Addiction Recovery (LDART)
October 10, 2025 updated by: Yale University
Piloting a Novel Social Support Intervention for Addiction Recovery
The purpose of this research study is to determine whether using a web-based intervention is feasible, acceptable, and helpful for people who engage in hazardous alcohol use and want to cut down or quit.
Study Overview
Detailed Description
This pilot study will determine the feasibility and acceptability of a novel online social support intervention (Let's Do Addiction Recovery Together!, abbreviated as LDART) that uses pre-recorded videos created by members of recovery support services to help individuals in early recovery from hazardous alcohol use sustain motivation during recovery and introduce them to freely available recovery support services in the community.
The investigators will recruit participants to use the web-based intervention daily for a month; they will also fill in questionnaires about their substance use and engagement with recovery support services at the beginning and end of the study to determine preliminary efficacy.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06510
- 1 Church St
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 18 years of age or older
- Is at the time of study participation residing in Connecticut, USA
- Is fluent in English and has a 6th grade reading level or higher
- Alcohol Use Disorders Identification Test (AUDIT) score of ≥8
- Has had at least one heavy drinking day in the past month
- Has some desire to cut down or quit their alcohol use
- Has a smartphone or computer with access to internet
Exclusion Criteria:
- Has vulnerable population status (e.g., pregnant people, prisoners)
- Is at the time of study participation receiving in-patient psychiatric treatment involving hospitalization
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: LDART
Participants will be asked to log onto the LDART website each night for a month.
|
LDART is a newly developed web-based social support intervention that can be accessed by smartphone or computer.
Each night, the participant sets a recovery goal for the next day (e.g., drink less than usual, go to a support group meeting).
The next night, they log on to LDART to indicate whether they reached their goal for the day.
Depending on their response, they will be shown either a celebratory or encouraging message from someone in the addiction recovery community, along with specific information on that person's recovery organization.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment Feasibility
Time Frame: Baseline
|
Feasibility of recruitment is measured as the number of adults who consent to study participation divided by the number of months the trial recruits for.
|
Baseline
|
|
Retention Feasibility
Time Frame: One-month post-intervention (Day 56)
|
Retention rate is calculated as the number of participants who complete the study divided by the number of participants who consented to participating in the study.
|
One-month post-intervention (Day 56)
|
|
Intervention Acceptability (Engagement With Intervention)
Time Frame: Duration of intervention (Days 1-28)
|
Acceptability is calculated as the number of nights participants login to LDART within the 28-day window.
|
Duration of intervention (Days 1-28)
|
|
Intervention Acceptability (Subjective Experience)
Time Frame: Post-intervention (Day 28)
|
Acceptability is measured with a 9-item self-report acceptability assessment questionnaire.
This comprises questions regarding the motivational and supportive properties of the content, perceptions on the frequency of engaging with the intervention, and whether they enjoyed using the intervention.
Each question is rated on a 5-point Likert scale, where higher values indicate greater acceptability.
There will also be two open-ended questions for participants to indicate what they liked and did not like about the intervention and ways to improve it.
Data reported here reflects percentage of participants who answered "agree" or "strongly agree" to the question: "I would recommend LDART to someone trying to cut down or quit drinking".
|
Post-intervention (Day 28)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Drinking Days Per Month
Time Frame: Day 0 (Pre-intervention), 28 (Post-intervention), and 56 (1-month post-intervention)
|
Timeline Follow Back is a validated, self-reported instrument that provides specific dates for alcohol use in the past 28 days, and the number of standard drinks consumed on each drinking day.
Percent Drinking Days Per Month is calculated as the percentage of days in the 28-day window in which one or more standard drinks is consumed for two consecutive windows.
|
Day 0 (Pre-intervention), 28 (Post-intervention), and 56 (1-month post-intervention)
|
|
Percentage of Heavy Drinking Days Per Month
Time Frame: Day 0 (Pre-intervention), 28 (Post-intervention), and 56 (1-month post-intervention)
|
Percent Heavy Drinking Days is calculated from the Timeline Follow Back instrument as the number of days in the 28-day window in which four/five or more standard drinks is consumed for women/men for two consecutive windows.
|
Day 0 (Pre-intervention), 28 (Post-intervention), and 56 (1-month post-intervention)
|
|
Hours Spent Engaging With Recovery Support Services
Time Frame: Day 0 (Pre-intervention), 28 (Post-intervention), and 56 (1-month post-intervention)
|
Self-reported total number of hours spent engaging in recovery support services (e.g., being at a recovery community center, attending a support group meeting) in the past 28-day time window for two consecutive windows.
|
Day 0 (Pre-intervention), 28 (Post-intervention), and 56 (1-month post-intervention)
|
|
World Health Organization Quality of Life - Brief Version
Time Frame: Day 0 (Pre-intervention), 28 (Post-intervention), and 56 (1-month post-intervention)
|
World Health Organization Quality of Life - Brief Version (WHOQOL-BREF) is a questionnaire with 24 items that correspond to four domains: physical health, psychological health, social relationships, and environment.
Each question is rated on a five-point Likert scale.
Each domain score is transformed based on the lowest possible score to create a modified range of 0-100 for each domain.
All four domain scores are then averaged to create a single score on a range of 0-100, where higher values indicate higher quality of life.
|
Day 0 (Pre-intervention), 28 (Post-intervention), and 56 (1-month post-intervention)
|
|
Brief Assessment of Recovery Capital
Time Frame: Day 0 (Pre-intervention), 28 (Post-intervention), and 56 (1-month post-intervention)
|
Brief Assessment of Recovery Capital (BARC) is a 10-item self-report measure of recovery capital with ten domains (substance use and sobriety, global psychological health, global physical health, citizenship and community involvement, social support, meaningful activities, housing and safety, risk-taking, coping and life functioning, recovery experience).
Total score ranges from 0-50, where higher values indicate higher recovery capital.
|
Day 0 (Pre-intervention), 28 (Post-intervention), and 56 (1-month post-intervention)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Marc N Potenza, MD, PhD, Yale University
- Principal Investigator: Li Yan McCurdy, PhD, Yale University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 26, 2024
Primary Completion (Actual)
July 15, 2024
Study Completion (Actual)
July 15, 2024
Study Registration Dates
First Submitted
August 23, 2023
First Submitted That Met QC Criteria
August 30, 2023
First Posted (Actual)
September 1, 2023
Study Record Updates
Last Update Posted (Estimated)
November 5, 2025
Last Update Submitted That Met QC Criteria
October 10, 2025
Last Verified
October 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2000035434
- 000 (Other Identifier: CTGTY)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol; Harmful Use
-
University of New MexicoNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol; Harmful UseUnited States
-
University of Massachusetts, WorcesterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol; Harmful UseUnited States
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedHeavy Drinking | Harmful; Use, AlcoholUnited States
-
Boston University Charles River CampusNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol; Harmful Use | Sex, UnsafeUnited States
-
KU LeuvenUnknownHarmful; Use, Alcohol | Hazardous; Use, Alcohol
-
Women's College HospitalRecruitingAlcohol; Harmful Use | Tobacco Use | Tobacco Use Cessation | Alcohol Use, UnspecifiedCanada
-
The Hong Kong Polytechnic UniversityNot yet recruitingHazardous Drinking | Harmful Alcohol Use
-
Sykehuset i Vestfold HFSykehuset Innlandet HF; University Hospital, Akershus; Trondheim University Hospital and other collaboratorsActive, not recruitingHarmful Alcohol UseNorway
-
University of Central FloridaEnrolling by invitationAlcohol Use, Underage | Harmful; Use, AlcoholUnited States
-
Daniela Romero ReyesUniversidad Nacional de Educación a DistanciaCompletedAlcohol; Harmful UseMexico
Clinical Trials on LDART
-
Yale UniversityCollege on Problems of Drug DependenceEnrolling by invitationMethamphetamine Use Disorder | Cocaine Use Disorder | Stimulant Use DisorderUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Enrolling by invitation